The adoption of blow fill seal (BFS) technology in Korea is poised to surge at an 8.0% CAGR through 2033. Initially, the demand for blow fill seal technology in Korea is projected to increase substantially, surpassing a value of US$ 18.5 million in 2023. Looking forward to 2033, the analysis of BFS technology adoption in Korea suggests it is on track to reach a valuation of US$ 39.9 million.
| Attributes | Details |
|---|---|
| Industry Size in Korea in 2023 | US$ 18.5 million |
| Expected Industry Size of Korea by 2033 | US$ 39.9 million |
| Forecasted CAGR between 2023 to 2033 | 8.0% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Principal Consultant
The demand outlook for BFS technology in Korea suggests that polyethylene (PE) is widely preferred, accounting for 60.6% of industry share in 2023. PE's malleability makes it ideal for the complicated molding procedures required in BFS technology. Its ability to be molded into various container forms meets the diverse packaging needs of pharmaceutical products, facilitating flexibility and customization in the manufacturing process.
| Leading Material for Blow Fill Seal (BFS) Technology in Korea | PE |
|---|---|
| Total Value Share (2023) | 60.6% |
The lightweight qualities of PE lead to easier handling and lower transportation costs. Its user-friendly features improve operational efficiency and logistical ease, meeting the demands of standardized supply chain management. Furthermore, many types of PE materials are recyclable, aligning with Korea’s sustainability aims and regulatory requirements for environmentally friendly packaging solutions. This characteristic promotes PE in the BFS technology industry as a sustainable and compliant choice that meets growing environmental criteria.
The demand outlook for BFS technology in Korea indicates that pharmaceuticals are the leading end use and captures 97.6% of the industry shares in 2023. The adaptability of BFS technology to meet the demands of the pharmaceutical sector for customized packaging solutions, including variable container sizes, shapes, and volumes, illustrates its versatility. This adaptability is crucial in addressing the diverse needs of the pharmaceutical industry.
| Leading End Use for Blow Fill Seal (BFS) Technology in Korea | Pharmaceuticals |
|---|---|
| Total Value Share (2023) | 97.6% |
The booming pharmaceutical industry in Korea is experiencing an enormous spike in demand for a wide range of pharmaceutical products. The potential of BFS technology to effectively handle this expanding demand, including the manufacturing of over-the-counter and prescription pharmaceuticals, positions it as an invaluable tool for the industry's expansion goals.
The competitive landscape of the blow fill seal (BFS) technology industry in Korea is characterized by a mix of international leaders, regional rivals, and adept innovators. Quality, regulatory compliance, and innovation are critical, and firms that excel in these areas are likely to prosper in Korea's competitive pharmaceutical packaging industry. Companies are increasingly focusing on sustainable materials and packaging solutions, which give them a competitive advantage. Sustainability fits with global trends and environmental laws, giving Korea’s eco-friendly BFS providers a competitive edge.
Strategies for Key Players to Tap into Potential Growth Opportunities
Recent Developments Observed in Blow Fill Seal (BFS) Technology in Korea
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Estimated Industry Size in 2023 | US$ 18.5 million |
| Projected Industry Size by 2033 | US$ 39.9 million |
| Anticipated CAGR between 2023 to 2033 | 8.0% CAGR |
| Historical Analysis of Demand for Blow Fill Seal (BFS) Technology in Korea | 2018 to 2022 |
| Demand Forecast for Blow Fill Seal (BFS) Technology in Korea | 2023 to 2033 |
| Report Coverage | Industry Size, Industry Trends, Analysis of key factors influencing Blow Fill Seal (BFS) Technology Adoption in Korea, Insights on Global Players and their Industry Strategy in Korea, Ecosystem Analysis of Local and Regional Korean Manufacturers |
| Key Cities Analyzed While Studying Opportunities in Blow Fill Seal (BFS) Technology in Korea | South Gyeongsang, North Jeolla, South Jeolla, Jeju |
| Key Companies Profiled | SK Chemicals; Rommelag Korea Co., Ltd.; UNISON Corporation; SHINJIN KOREA CO., LTD.; Korea BFS Co., Ltd.; KORIL; Hanmi Pharmaceutical Co., Ltd.; HANWHA Corporation; Kanglim Co., Ltd.; DAIHAN Pharmaceutical Co., Ltd. |
The expected CAGR for BFS technology in Korea through 2033 stands at a remarkable 8.0%.
Anticipated demand for BFS technology in Korea is projected to reach US$ 39.9 million by 2033.
The rising pharmaceutical industry expansion drives the demand for blow fill seal technology in Korea.
BFS technology providers emphasize innovation by incorporating cutting-edge technologies.
Polyethylene (PE) is the preferred material type in BFS technology in Korea.
1. Executive Summary
1.1. Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Bottles
5.3.1.1. 0.2-100ML
5.3.1.2. 100-500ML
5.3.1.3. Above 500ml
5.3.2. Ampules
5.3.2.1. 0.1-10ml
5.3.2.2. 10-100ml
5.3.3. Vials
5.3.3.1. 0.1-10ml
5.3.3.2. 10-50ml
5.3.4. Others(prefilled syringes & Injectables)
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Material Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Material Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Material Type, 2023 to 2033
6.3.1. PE
6.3.1.1. LDPE
6.3.1.2. HDPE
6.3.2. PP
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Material Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Material Type, 2023 to 2033
7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By End Use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End Use, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End Use, 2023 to 2033
7.3.1. Pharmaceuticals
7.3.1.1. OPthalmic
7.3.1.2. Injectables
7.3.1.3. Biologics
7.3.1.4. Wound Care
7.3.1.5. Respiratory
7.3.2. Food & Beverage
7.3.3. Cosmetics & Personal Care
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis By End Use, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End Use, 2023 to 2033
8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. South Gyeongsang
8.3.2. North Jeolla
8.3.3. South Jeolla
8.3.4. Jeju
8.3.5. Rest of Korea
8.4. Market Attractiveness Analysis By Region
9. South Gyeongsang Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Product Type
9.2.2. By Material Type
9.2.3. By End Use
9.3. Market Attractiveness Analysis
9.3.1. By Product Type
9.3.2. By Material Type
9.3.3. By End Use
9.4. Key Takeaways
10. North Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Product Type
10.2.2. By Material Type
10.2.3. By End Use
10.3. Market Attractiveness Analysis
10.3.1. By Product Type
10.3.2. By Material Type
10.3.3. By End Use
10.4. Key Takeaways
11. South Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Product Type
11.2.2. By Material Type
11.2.3. By End Use
11.3. Market Attractiveness Analysis
11.3.1. By Product Type
11.3.2. By Material Type
11.3.3. By End Use
11.4. Key Takeaways
12. Jeju Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Product Type
12.2.2. By Material Type
12.2.3. By End Use
12.3. Market Attractiveness Analysis
12.3.1. By Product Type
12.3.2. By Material Type
12.3.3. By End Use
12.4. Key Takeaways
13. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Product Type
13.2.2. By Material Type
13.2.3. By End Use
13.3. Market Attractiveness Analysis
13.3.1. By Product Type
13.3.2. By Material Type
13.3.3. By End Use
13.4. Key Takeaways
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Product Type
14.3.3. By Material Type
14.3.4. By End Use
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Unither Pharmaceuticals
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.1.5.2. Product Strategy
15.1.1.5.3. Channel Strategy
15.1.2. HealthStar
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.2.5.2. Product Strategy
15.1.2.5.3. Channel Strategy
15.1.3. SIFI Spa
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.3.5.2. Product Strategy
15.1.3.5.3. Channel Strategy
15.1.4. QuadroPack
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.4.5.2. Product Strategy
15.1.4.5.3. Channel Strategy
15.1.5. Weiler Engineering Inc.
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.5.5.2. Product Strategy
15.1.5.5.3. Channel Strategy
15.1.6. GlaxoSmithKline plc
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.6.5.2. Product Strategy
15.1.6.5.3. Channel Strategy
15.1.7. Takeda Pharmaceuticals International AG
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.7.5.2. Product Strategy
15.1.7.5.3. Channel Strategy
15.1.8. Nephron Pharmaceuticals Corporation
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.8.5.2. Product Strategy
15.1.8.5.3. Channel Strategy
15.1.9. Horizon Pharmaceutical Inc
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.9.5.2. Product Strategy
15.1.9.5.3. Channel Strategy
15.1.10. Brevetti Angela S.R.L
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
15.1.10.5.2. Product Strategy
15.1.10.5.3. Channel Strategy
15.1.11. Recipharm AB
15.1.11.1. Overview
15.1.11.2. Product Portfolio
15.1.11.3. Profitability by Market Segments
15.1.11.4. Sales Footprint
15.1.11.5. Strategy Overview
15.1.11.5.1. Marketing Strategy
15.1.11.5.2. Product Strategy
15.1.11.5.3. Channel Strategy
15.1.12. Laboratorios SALVAT, S.A
15.1.12.1. Overview
15.1.12.2. Product Portfolio
15.1.12.3. Profitability by Market Segments
15.1.12.4. Sales Footprint
15.1.12.5. Strategy Overview
15.1.12.5.1. Marketing Strategy
15.1.12.5.2. Product Strategy
15.1.12.5.3. Channel Strategy
15.1.13. The Ritedose Corporation
15.1.13.1. Overview
15.1.13.2. Product Portfolio
15.1.13.3. Profitability by Market Segments
15.1.13.4. Sales Footprint
15.1.13.5. Strategy Overview
15.1.13.5.1. Marketing Strategy
15.1.13.5.2. Product Strategy
15.1.13.5.3. Channel Strategy
15.1.14. Unicep Packaging, LLC
15.1.14.1. Overview
15.1.14.2. Product Portfolio
15.1.14.3. Profitability by Market Segments
15.1.14.4. Sales Footprint
15.1.14.5. Strategy Overview
15.1.14.5.1. Marketing Strategy
15.1.14.5.2. Product Strategy
15.1.14.5.3. Channel Strategy
15.1.15. Pharmapack Co. Ltd
15.1.15.1. Overview
15.1.15.2. Product Portfolio
15.1.15.3. Profitability by Market Segments
15.1.15.4. Sales Footprint
15.1.15.5. Strategy Overview
15.1.15.5.1. Marketing Strategy
15.1.15.5.2. Product Strategy
15.1.15.5.3. Channel Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Explore Packaging Insights
View Reports
Blow Fill Seal Technology Industry Analysis in Korea
